Clinical Trial Update: A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Atazanavir and Nelfinavir, each with two NRTIs, in HIV-infected patients who failed prior therapy without a protease inhibitor, has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• ATAZANAVIR (atazanavir)
• Nelfinavir (nelfinavir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | Phase 3 | Status: TERMINATED